Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report.

Qian HZ, Mitchell VJ, Bebawy S, Cassell H, Perez G, McGowan CC, Sterling TR, Vermund SH, D'Aquila R, Hulgan T
BMC Infect Dis. 2014 14: 508

PMID: 25234368 · PMCID: PMC4175271 · DOI:10.1186/1471-2334-14-508

BACKGROUND - There have been inconsistent findings on the association between current drug use and HIV disease progression and virologic suppression. Drug use was often measured using self-report of historical use. Objective measurement of current drug use is preferred.

METHODS - In this cross-sectional study, we assessed drug use through Computer-Assisted Self Interviews (CASI) and point-of-care urine drug screen (UDS) among 225 HIV-infected patients, and evaluated the association between current drug use and virologic suppression.

RESULTS - About half (54%) of participants had a positive UDS, with a lower self-reported rate by CASI (42%) (Kappa score = 0.59). By UDS, 36.0% were positive for marijuana, 25.8% for cocaine, 7.6% for opiates, and 2.2% for methamphetamine or amphetamine. Factors associated with virologic suppression (plasma HIV RNA <50 copies/mL) were Caucasian race (P = 0.03), higher CD4 count (P < 0.01), current use of antiretroviral therapy (ART) (P < 0.01), and a negative UDS (P < 0.01). Among 178 current ART users, a positive UDS remained significantly associated with lower likelihood of virologic suppression (P = 0.04).

CONCLUSIONS - UDS had good agreement with CASI in detecting frequently used drugs such as marijuana and cocaine. UDS at routine clinic visits may provide "real-time" prognostic information to optimize management.

MeSH Terms (20)

Adult Aged Anti-HIV Agents CD4 Lymphocyte Count Cross-Sectional Studies Disease Progression Drug Users Female HIV-1 HIV Infections Humans Illicit Drugs Interviews as Topic Male Middle Aged Point-of-Care Systems Self Report Substance-Related Disorders Viral Load Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: